Xu, Ruihan <br/><br/>
Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD- L1-dependent T cell immunization.  [electronic resource] 

 -  Pharmacological research  02 2020 
 - 104623 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2019.104623  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>B7-H1 Antigen--immunology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Combinations<br/>Drug Synergism<br/>Drugs, Chinese Herbal--pharmacology<br/>Female<br/>Fluorouracil--pharmacology<br/>Humans<br/>Immunization<br/>Male<br/>Mice<br/>Middle Aged<br/>Programmed Cell Death 1 Receptor--immunology<br/>Stomach Neoplasms--drug therapy<br/>T-Lymphocytes--drug effects